Tradestie Institutional Equity Comparison Engine

LH vs AMS โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

LH Overall Edge

LH Captures Institutional Edge (4โ€“0 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Labcorp Holdings Inc. (LH) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, LH trades at 19.0x Forward P/E with 11.2% operating margin (+6.9% YoY revenue) versus AMS at 44.6x Forward P/E and -7.4% operating margin (+19.2% YoY). In options structure, LH sits in CONSOLIDATION (16th %ile IV; Dealer Gamma Walls on Pro) against AMS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner LH
LH 19.0x vs AMS 44.6x Fwd P/E
Growth & Margin Winner LH
Op Margin 11.2% vs -7.4% ยท YoY +6.9% vs +19.2%
Momentum & Technical Winner LH
1Y +39.0% vs -52.2% ยท 52W Pos 98% vs 6%
Options & Structure Winner LH
CONSOLIDATION (16th %ile IV) vs UNCLASSIFIED (N/A IV)
LH NYSE
Labcorp Holdings Inc.
Services-Medical Laboratories
$372.46
+0.53% 1D
Market Cap $30.1B
1M Return +17.14%
1Y Return +39.05%
Forward P/E 19.0x
Unified AI Score
40.8 / 100 SELL
Tech 17.0 Fund 35.0 Flow 58.0 Mom 31.1
AMS NYSE American
American Shared Hospital Services
Services-Medical Laboratories
$1.07
-0.93% 1D
Market Cap $7.2M
1M Return -16.41%
1Y Return -52.23%
Forward P/E 44.6x
Unified AI Score
33.8 / 100 SELL
Tech 24.0 Fund 38.0 Flow 50.0 Mom 30.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: LH +39.05% AMS -52.23% Spread: +91.28 pp (LH Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period LH Revenue AMS Revenue LH Op. Margin AMS Op. Margin Margin Edge
FY2018 $11.3B $20M 11.7% 9.4% LH
FY2019 $11.6B $20M 11.5% 7.5% LH
FY2020 $14.0B $20M 17.5% -53.1% LH
FY2021 $13.1B $20M 23.2% 7.7% LH
FY2022 $11.9B $20M 12.1% 12.3% AMS
FY2023 $12.2B $20M 6.0% 1.3% LH
FY2024 $13.0B $30M 8.4% -9.9% LH
FY2025 $13.9B $30M 9.9% -12.8% LH

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: LH (9) vs AMS (1)
Institutional Metric LH AMS Criterion Row Winner
Market Capitalization Scale $30.1B $7.2M Larger Scale LH
Trailing P/E Ratio Valuation 30.4x 44.6x Lower Multiple LH
Forward P/E Ratio Valuation 19.0x 44.6x Lower Multiple LH
Revenue Growth (YoY) Growth +6.9% +19.2% Higher Growth AMS
Operating Margin (TTM) Profitability 11.2% -7.4% Higher Margin LH
Net Profit Margin Profitability 6.9% -5.8% Higher Margin LH
Return on Equity (ROE) Capital Efficiency 11.4% -12.1% Higher ROE LH
52-Week Range Position Momentum 98% ($245โ€“$375) 6% ($1โ€“$2) Stronger Trend LH
Beta / 30D Volatility Risk Regime 0.37ฮฒ ยท 36% Vol 0.18ฮฒ ยท 46% Vol Lower Realized Risk LH
Unified Institutional Score Composite Signal 40.8 / 100 (SELL) 33.8 / 100 (SELL) Higher Composite LH

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full LH vs AMS Buy Guide
LH CONSOLIDATION
59d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 16th %ile
IV Regime Compressed (<25th %ile)
Live LH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
AMS UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live AMS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither LH nor AMS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.